Literature DB >> 8933512

Is microstaging of early invasive cancer of the urinary bladder possible or useful?

C E Platz1, M B Cohen, M P Jones, D B Olson, C F Lynch.   

Abstract

Reports suggest that it is possible and useful to classify T1 (Stage A) carcinomas of the urinary bladder into subgroups dependent on the depth of invasion as defined by the muscularis mucosae (MM). In an attempt to evaluate the reproducibility of these findings, we reviewed the slides from 77 cases of T1 bladder cancer diagnosed in 1983 in Iowa residents. The cases were identified through a statewide cancer registry. Slides and pathology reports were obtained from the original laboratories. Two pathologists independently evaluated each case, most (74 cases) of which were transurethral resections, for the presence or absence of MM and three levels of invasion (lamina propria, MM, and submucosa). Disagreements were resolved by simultaneous review resulting in a consensus diagnosis. Because of the population-based source, tissue had been obtained by multiple urologists and processed in multiple laboratories, resulting in noticeable variation in quality of material. Interobserver agreement for the level of invasion was poor between the two pathologists (kappa = 0.22; 95% C.I. = 0.08-0.36). Consensus resulted in 34 cases (44.2%) invasive to the lamina propria, 23 (29.9%) to the MM, and 11 (14.3%) to the submucosa. The level was indeterminate in nine (11.7%). All of the 77 cases were followed until death or 1993-95, with 57 patients dying during this interval. There were no significant differences in survival for each level of invasion (lamina propria, MM, submucosa) and the indeterminate cases, as determined by either consensus or individual observer evaluation. Our findings suggest that microstaging of early invasive bladder cancer is technically difficult and, at least in cases derived from various urologists and laboratories, does not yield a prognostically significant separation.

Entities:  

Mesh:

Year:  1996        PMID: 8933512

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

Review 1.  Current problems and needs in the treatment of pT1 G3 bladder carcinoma.

Authors:  Francisco Jose Martínez Portillo; Peter Alken
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression.

Authors:  Shugo Yajima; Soichiro Yoshida; Taro Takahara; Yuki Arita; Hiroshi Tanaka; Yuma Waseda; Minato Yokoyama; Junichiro Ishioka; Yoh Matsuoka; Kazutaka Saito; Kazunori Kihara; Yasuhisa Fujii
Journal:  Eur Radiol       Date:  2019-03-19       Impact factor: 5.315

3.  Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder.

Authors:  Vincenzo DE Marco; Maria Angela Cerruto; Carolina D'Elia; Matteo Brunelli; Oscar Otte; Anila Minja; Claudio Luchini; Giovanni Novella; Stefano Cavalleri; Guido Martignoni; Walter Artibani
Journal:  Mol Clin Oncol       Date:  2014-05-08

4.  A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

Authors:  Yann Neuzillet; Xavier Paoletti; Slah Ouerhani; Pierre Mongiat-Artus; Hany Soliman; Hugues de The; Mathilde Sibony; Yves Denoux; Vincent Molinie; Aurélie Herault; May-Linda Lepage; Pascale Maille; Audrey Renou; Dimitri Vordos; Claude-Clément Abbou; Ashraf Bakkar; Bernard Asselain; Nadia Kourda; Amel El Gaaied; Karen Leroy; Agnès Laplanche; Simone Benhamou; Thierry Lebret; Yves Allory; François Radvanyi
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

5.  Prognostic Significance of Substaging according to the Depth of Lamina Propria Invasion in Primary T1 Transitional Cell Carcinoma of the Bladder.

Authors:  Ji Yong Lee; Hee Jae Joo; Dae Sung Cho; Sun Il Kim; Hyun Soo Ahn; Se Joong Kim
Journal:  Korean J Urol       Date:  2012-05-18

Review 6.  How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?

Authors:  Seok Joong Yun; Seon-Kyu Kim; Wun-Jae Kim
Journal:  Investig Clin Urol       Date:  2016-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.